Continuous Renal Replacement Therapy Market

1. Continuous Renal Replacement Therapy Market Highlights According to MRFR analysis, The continuous renal replacement therapy market size is expected to reach USD 2,982.63 million by 2030 at 8.9% CAGR during the forecast period (2022 - 2030) The continuous renal replacement therapy market trends is expected to have lucrative growth opportunities during the forecast period. This is due to increasing kidney-related diseases, rising comorbidities, and increased development of healthcare infrastructure. As per the research, CRRT demand is increasing in developing regions owing to the rising geriatric population and growing population, which will further support the market during the forecast period. In addition, growth strategies include product launches, contractual agreements, mergers, and acquisitions among key players, which further open up market opportunities. The leading market players forming strategic initiatives, including Baxter International, Inc. (US), Medtronic plc (Ireland), Fresenius Medical Care (US), B. Braun Medical, Inc. (US), and Nikkiso Co. (Japan), further propel the market’s growth. CRRT is a renal replacement therapy that operates continuously, 24 hours a day, providing slow and continuous removal of solutes and fluids from the patient's bloodstream. Unlike intermittent hemodialysis (IHD), which is performed a few times a week, CRRT offers a more gentle and sustained approach to renal support. This therapy is often preferred for critically ill patients who cannot tolerate the rapid changes in fluid and electrolytes that occur during traditional hemodialysis. Continuous Renal Replacement Therapy MarketRegional Analysis The North America region is expected to dominate the market during the forecast period. This is due to several factors, including the increasingly sedentary lifestyle & physical inactivity and strategic alliances among regional market players. Furthermore, sedentary lifestyles and physical inactivity further increase the chances of diabetes, obesity, and heart failure. Atrial fibrillation patients are more likely to suffer from acute kidney injury. As per the Centers for Disease Control and Prevention, in 2019, there were 183,321 deaths owing to atrial fibrillation. The Europe continuous renal replacement therapy market is projected to show significant growth during the forecast period. This is due to the increasing prevalence of arrhythmia and other CVDs, the rising number of cardiac surgical procedures, and the increasing development of healthcare infrastructure. The Asia-Pacific market is expected to have the fastest growth owing to the geriatric population, growing population, physical inactivity & sedentary lifestyle. According to the study, a substantial portion of the workforce in Asia-Pacific is pursuing a sedentary lifestyle, which subsequently promotes obesity and diabetes. As a result, the possibility of developing CVDs is increased even more by the rising adoption of sedentary lifestyle, which boosts the risk of acute kidney failure. Furthermore, in the Rest of the World, the market is projected to show sluggish growth owing to a dearth of physicians practicing continuous renal replacement therapy. However,

2. the increasing prevalence of CVDs such as ischemic heart disease and rheumatic heart disease in Africa and Latin America further increases the chances of acute kidney failure and propels the market growth. Continuous Renal Replacement Therapy Market Segmentation The global continuous renal replacement therapy market insights has been segmented into product, modality, age group, and end user. Based on product, the market has been segmented into dialysates and replacement fluids, disposables, and CRRT system. Dialysates and replacement fluids are projected to have the highest market share during the forecast period owing to their frequent use in the CRRT system. Moreover, several therapies do not use the same fluids for filtration, which further propels segment growth. Based on modality, the market has been segmented into continuous venovenous hemofiltration (CVVH), continuous venovenous diafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). Continuous venovenous hemofiltration is projected to hold the highest share in 2021 because this is suitable for patients who are not comfortable with hemodialysis. Moreover, during the pandemic, CVVH therapy has been performed impulsively. On the basis of age group, the market has been bifurcated into geriatric, adults, and pediatric & neonates. Adults are expected to have the largest market share in 2021, owing to increasing kidney related diseases in developing regions in this age group. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and specialty clinics. Hospitals are expected to have lucrative growth opportunities as the number of cardiac surgical procedures increases and the number of kidney-related diseases increases. Key Players Some of the key market players are Baxter International, Inc. (US), Medtronic plc (Ireland), Fresenius Medical Care (US), B. Braun Medical Inc. (US), Nikkiso Co. (Japan), Asahi Kasei Corporation (Japan), Toray Medical Co. Ltd (Japan), Infomed SA (Switzerland), SWS Heamodialysis Care Co. Ltd (China), Medites Pharma spol. s.r.o. (Czech Republic), and Others. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013

3. United States of America +1 628 258 0071 Email: sales@marketresearchfuture.com